Clinical Trial Update: A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure [NA]

View source ↗

Summary

A terminated clinical trial evaluating a wearable device that delivers glucose into recirculated peritoneal dialysis fluid for ultrafiltration in heart failure …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Heart Failure

Snippet

Sponsor: Triomed AB | Conditions: Heart Failure, Cardio-Renal Syndrome | NA | Status: TERMINATED